Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial
O'Brien et al., JAMA, doi:10.1001/jama.2021.24939768
https://c19early.org/obrien2.html